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Studies on tracheorelaxant and anti-inflammatory
activities of rhizomes of Polygonatum verticillatum
Haroon Khan1,2,4*, Muhammad Saeed1, Malik Hassan Mehmood2, Najeeb-ur Rehman2,7, Naveed Muhammad1,8,
Ikram-ul Haq3, Nadeem Ashraf5, Kamal Eldin H El-Tahir6 and Anwarul-Hassan Gilani2

Abstract
Background: The present study describes the tracheorelaxant and anti-inflammatory effects of Polygonatum
verticillatum which may support its medicinal use in hyperactive airway complaints and inflammatory disorders.
Methods: The tracheorelaxant activity of crude extract of the rhizomes of P. verticillatum (PR) was assessed in
isolated guinea-pig tracheal tissues immersed in tissue organ bath filled with Tyrode’s solution and a continuous
supply of carbogen gas (95% O2 and 5% CO2). The contractile and relaxant responses of the tissue were measured
using isometric transducers coupled with Power-Lab data acquisition system. The anti-inflammatory effect was
evaluated in carrageenan-induced rat paw edema model, while the lipoxygenase inhibitory activity was performed
in the in-vitro assay. Various chromatographic and spectroscopic techniques were used for the isolation and
characterization of pure molecules.
Results: In isolated guinea-pig tracheal preparations, PR caused complete inhibition of the high K+ (80 mM) and
carbachol-induced contractions however, it was more potent against K+ than CCh, similar to verapamil.
Pretreatment of the tissue with PR, displaced the Ca2+ concentration-response curves to the right, similar to that
induced by verapamil, indicating the presence of Ca2+ channel blocking like activity. When tested on carrageenaninduced rat paw edema, PR demonstrated a marked reduction in edema with 65.22% protection at 200 mg/kg,
similar to aspirin. In the in-vitro assay, PR showed lipoxygenase inhibitory activity (IC50: 102 ± 0.19 μg/mL), similar to
baicalein. Bioactivity-guided fractionation led to the isolation of 2-hydroxybenzoic acid and β-sitosterol.
Conclusions: These results indicate that the plant possesses tracheorelaxant, mediated possibly through a Ca2+
channel blockade mechanism, and anti-inflammatory activities, which may explain the medicinal use of this plant in
airway disorders and inflammation.
Keywords: Polygonatum verticillatum, Bronchodilator, Ca2+ antagonist, Anti-inflammatory, 2- Hydroxybenzoic acid,
β-sitosterol

Background
Polygonatum verticillatum [L.] All. (Nooreallam) belonging to family Liliaceae or Convallariaceae possesses
around 57 species and is commonly found in East Asia,
China and Japan [1,2]. In different traditional systems of
medicine, Polygonatum is popular for its use in pulmonary disorders like asthma and inflammation [3,4], in
addition to its multiple other health benefits such as,
antituberculant, antidiabetic, antihypertensive, diuretic,
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analgesic and antipyretic activities [4,5]. P. verticillatum
has also been studied for its analgesic [6,7], antimalarial
and antioxidant [8], metal accumulant [9], insecticidal
[10], antibacterial [11] and antipyretic [12] activities.
A variety of phytochemical constituents have been isolated from different species of the genus Polygonatum;
primarily: saponins, alkaloids, glycosides, flavonoids and
phytohormones. These groups of compounds show different types of activities. Long chain esters from this
plant exhibit potent tyrosinase inhibition [13], alkaloid,
homoisolflavanone, triterpenoid and steroidal saponin
show profound antimicrobial and anticancer properties [14-17] and emodin from Polygonatum has shown
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Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ameliorating effects on the memory consolidation [18].
Several compounds have also been isolated from the
rhizomes of P. verticillatum including lectins [19], 5hydroxymethyl-2-furaldehyde and diosgenin [8]. There is
no study to the best of our knowledge reporting its
usefulness in hyperactive airways disorders or inflammation. This study describes the tracheorelaxant and antiinflammatory activities of P. verticillatum to provide a
scientific background to its medicinal use in hyperactive
airways complaints like asthma or inflammatory conditions. The in-vivo and in-vitro experimental studies have
been designed, followed by bioactivity-guided isolation
of its secondary metabolites.

Reckitt & Colman, Pakistan. Chemicals used for making Tyrode’s solution were: potassium chloride (Sigma
Chemicals Co., St. Louis, MO, USA), calcium chloride,
glucose, magnesium chloride, sodium bicarbonate, sodium
dihydrogen phosphate (Merck, Darmstadt, Germany) and
sodium chloride from BDH Laboratory supplies, Poole,
England. All chemicals used were of highest grade available, and were solubilized in distilled water/saline while
carrageenan was used as suspension with acacia.

Method
Plant material

P. verticillatum (whole plant) was collected from the
District Swat, Khyber Pukhtonkhawa, Pakistan, in JulyAug 2007. The botanical characterization of the plant
material was executed by the Taxonomy Department of
PCSIR Laboratories Peshawar and a specimen with catalogue No: 9970 (PES) was deposited in the herbarium of
PCSIR Laboratories Peshawar.
Plant extraction

Air-shade dried rhizomes of the P. verticillatum (8 kg)
were grounded to a fine powder. The powdered material
was soaked in aqueous-methanol (30:70) for three days
while shaking occasionally [20] and filtered through a
muslin cloth and Whatman filter paper (Maidstone, UK)
simultaneously. This procedure was repeated three times
and all the pooled filtrates were evaporated on a rotary
evaporator (model RE-111, Buchi, Flawil, Switzerland)
under reduced pressure (−760 mm Hg) to obtain a dark
greenish semi-solid material, yielding 27.50 wt/wt%.
Experimental animals

A total of thirty Wistar rats (190–260 g) and five adult
local guinea-pigs (1.2 − 1.6 kg) of either sex were kept
under standard laboratory conditions at 25 ± 2°C and a
relative humidity of 40-70%. The light cycle was maintained as 12 h dark: 12 h light. They were fed with a
laboratory diet ad libitum and allowed free access to
drinking water. All the experiments were performed in
compliance with the rulings of the Institute of Laboratory Animal Resources, Commission on Life Sciences,
National Research Council [21] and approved by the
local Ethical Committee of the Karachi University.
Drugs and reagents

Carrageenan, carbachol (CCh), verapamil hydrochloride,
soybean lipoxygenase, linoleic acid sodium salt and
baicalein were purchased from the Sigma Chemicals Co.,
St. Louis, MO, USA and aspirin was obtained from the

Isolated guinea-pig tracheal tissue

The trachea was obtained from guinea-pigs and preserved in physiological solution (Kreb’s solution). Rings
containing a couple of cartilages were formed from a
tracheal tube approximately 2–3 mm wide. Rings were
cut into strips by a longitudinal cut on the ventral side
reverse to the smooth muscle [22]. The strips were
suspended in a tissue bath (20 mL) containing Kreb’s
solution (pH 7.4), maintained at 37°C and aerated
with a mixture of 95% oxygen and 5% carbon dioxide
(carbogen). Tracheal strips were maintained at 1 gram
constant tension during the course of experiment. The
tissues were granted 1 h to equilibrate prior to the introduction of test material. Before determining the inhibitory activity of the plant extract, the isolated tracheal
tissues were stabilized with high K+ (80 mM) and CCh
(1 μM) until constant responses of each agonist were
achieved (usually 3–4 concentrations). The sustained
contractions were obtained using CCh and K+ separately
and the inhibitory effect was assessed using the cumulative addition of the test material. Isometric responses
were recorded on a Grass model 7 Polygraph (Grass instrument company, Quincy, MA, USA). The inhibition
of the high K+-induced contractions indicates Ca2+ antagonist activity [23], which was confirmed by constructing
the Ca2+ concentration-response curves in the absence
and presence of increasing concentrations of the plant
material.
Carrageenan-induced edema

The carrageenan-induced rat hind paw edema test was
conducted as described previously [24]. The test animals
were divided in to five groups (n = 6). Group Ι (the control group) received normal saline (10 mL/kg). The rats
of group ΙΙ, ΙΙΙ and ΙV received the test extract (50, 100
or 200 mg/kg i.p.), while, group V (positive control)
received aspirin (100 mg/kg i.p.). Following 30 min of
the treatments, acute inflammation was induced by subplantar injection of 0.1 mL of 1% suspension of carrageenan with 2% gum acacia in normal saline, in the right
hind paw of the rats. The paw volume was estimated
with the help of plethysmometer (Ugo Basile, Italy) at
1st, 2nd, 3rd, 4th and 5th h after the carrageenan injection.
Statistics was applied on the raw data for the calculation
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of reduction in rat paw volume (mL) for each group
against saline, followed by the calculation of percent reduction in the rat paw using the following formula:

75 MHz): δ 113.9 (C-1), 163.2 (C-2), 118.1 (C-3), 136.6
(C-4), 120.0 (C-5), 131.5 (C-6), 173.5 (C-1′).
Characterization of β-sitosterol (B)

% inhibition ¼ 1  ðdt=dcÞ  100
where “dt” is the difference in paw volume in the treated
group and “dc” the difference in paw volume in the control group.
Soybean lipoxygenase inhibitory assay

The lipoxygenase (LOX) inhibition assay was conducted
by using different dilutions of the PR by following previously described method [25]. Soybean lipoxygenase and
linoleic acid were used. Equal volume (10 mL) of the
sample (PR) and standard drug along with 20 mL of
solvent lipoxygenase solution simultaneously were mixed
followed by incubation for 5 min at 25°C. The biochemical reaction was initiated by the addition of linoleic
acid solution (10 μL) as substrate and the absorption
change with the formation of (9Z,11E)-13S)-13-hydroperoxyoctadeca-9, 11-dienoate was followed for 10 min
at 234 nm. The test sample and the control were dissolved in 50% ethanol. All the reactions were performed
in triplicate. Baicalein was used as a positive control.
The median effective concentrations (IC50 values) were
calculated using the EZ-Fit Enzyme Kinetics program
(Perrella Scientific Inc., Amherst, USA).

Colourless amorphous powder, M.P. 135-136°C, HREIMS:
m/z 414.3845 (calculated for C29H50O as 414.3855).
1
H NMR (CHCl3, 300 MHz): δ 3.65 (m), 5.35 (m), 0.67 (s),
0.99 (s), 0.91 d (J = 6.3 Hz), 0.83 d (J = 6.8 Hz), 0.79 d
(J = 6.8 Hz), 0.82 t (J = 7.0 Hz). 13C NMR (CDCl3,
75 MHz): δ 37.1 (C-1), 31.6 (C-2), 72.1 (C-3), 42.4 (C-4),
139.5 (C-5), 120.0 (C-6), 32.5 (C-7), 35.3 (C-8), 49.8 (C-9),
36.2 (C-10), 22.1 (C-11), 40.3 (C-12), 43.1 (C-13), 56.9
(C-14), 24.7 (C-15), 27.9 (C-16), 54.7 (C-17), 12.1 (C-18),
18.7 (C-19), 40.1 (C-20), 21.5 (C-21), 33.8 (C-22), 28.8
(C-23), 50.5 (C-24), 26.7 (C-25), 18.9 (C-26), 21.5 (C-27),
23.1 (C-28), 12.6 (C-29).
Statistical analysis

Results obtained from the pharmacological experiments
are expressed as mean values ± S.E.M. One-way ANOVA
test was employed for comparison of the significant differences among the groups followed by Dunnet’s multiple comparison post-test. A probability of P < 0.05 was
considered as significant. Concentration–response curves
were analyzed by nonlinear regression using GraphPad
program (GraphPAD, San Diego, CA, USA).

Results
Effect of PR on guinea-pig tracheal tissue

Isolation of pure molecules

A sample of 80 g of the aqueous-methanol extract of P.
verticillatum rhizomes (PR) was subjected to column
chromatography over silica gel (column grade) for the
isolation of pure chemical compounds. The sample was
loaded in a glass column over silica gel for adsorption
that acts as stationary phase. The column was initiated
with 100% n-Hexane as eluent (mobile phase). Polarity
of mobile phase was enhanced gradually with regular
monitoring of the isolate status over TLC, it resulted in
12 sub-fractions (P1-P12). Similar with methanol/chloroform gradient, 9 subfractions (M1-M9) were obtained.
When sub-fraction P9 was purified through column
chromatography, 2-Hydroxybenzoic acid (A) was isolated in the colorless crystals form (1A). Subfraction P11
was re-chromatographed over silica gel. While eluting
with chloroform: hexane; (8:2), β-Sitosterol (B) was isolated as colorless amorphous powder (1B).

When PR was studied for its inhibitory effect against
high K+ (80 mM) and CCh (1 μM) induced contractions
in guinea-pig tracheal preparations, it caused inhibitory
effects at the dose range of 0.01-10 mg/mL in a dosedependent manner with greater potency against K+
(Figure 1a), similar to that of verapamil, which exhibited
relaxation at the dose range of 0.03-3 μM (Figure 1c).
To confirm the Ca2+ antagonist-like effect, the concentration-response curves (CRCs) of Ca2+ were constructed in the absence and presence of different doses of the
plant extract, in Ca2+-free and K+ rich medium. Pretreatment of PR at the doses of 0.03 and 0.1 mg/mL,
displaced the CRCs of Ca2+ to the right with suppression
of the maximum response (Figure 1b), similar to that
caused by verapamil, which also displaced the Ca2+
CRCs to the right with suppression of the maximum response at tested doses of 0.003 and 0.01 μM (Figure 1d).
Effects of PR on carrageenan-induced rat paw edema

Characterization of 2-Hydroxybenzoic acid (A)

Colorless crystals, M.P. 159-160°C, HREIMS: m/z 138
(Calcd. for C7H6O3; 138.12), 1H NMR (CHCl3, 300 MHz):
δ 6.89 broad d (J = 8.4 Hz), 7.42 dt (J = 1.8, 8.4 Hz), 6.85 t
(J = 7.8 Hz), 7.83 dd (J = 1.8, 8.4), 13C NMR (CDCl3,

PR demonstrated marked reduction (P < 0.01) in edema
showing anti-inflammatory activity at the test doses of
50, 100 and 200 mg/kg, similar to that caused by aspirin
(Table 1). The data show that the effect is dose and
time-dependent with a peak effect obtained after 3 h of
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Figure 1 Dose-dependent inhibitory effect of the aqueous-methanol extract of P. verticillatum Rhizomes, PR (a) and verapamil (c) on
carbachol (CCh) and K+ (80 mM)-induced contractions, and the dose–response curves of Ca2+ created in the absence and presence of
increasing concentrations of PR (b) and verapamil (d) in isolated guinea-pig jejunum preparation. Data stand for mean ± SEM of 3–5
different experimental findings.

administration of PR (200 mg/kg), similar to the effect
of aspirin.

compared with that of the standard drug, baicalaim
(22.6 ± 0.09 μg/mL, n = 3).

Effect of PR on lipoxygenase activity

Isolation of pure molecules

When tested for inhibition of soybean lipoxygenase by
the UV absorbance based enzyme assay, PR showed a
significant activity against lipoxygenase with resultant
IC50 value of 102 ± 0.19 μg/mL (mean ± SEM, n = 3)

The structures of isolated molecules, 2-hydroxybenzoic
acid (a) and β-sitosterol (b) were confirmed by mass and
NMR spectral data available in literature [26,27] and
shown in Figure 2.

Table 1 Anti-inflammatory effect of the aqueous-methanol extract of P. verticillatum Rhizomes (PR) in
carrageenan-induced hind paw edema in rats
Group

Dose
mg/kg

Increase in paw volume (Mean ± SEM) in mL
1h

2h

3h

4h

5h

Saline

10

0.70 ± 0.031

0.69 ± 0.040

0.69 ± 0.049

0.70 ± 0.067

0.72 ± 0.053

PR

Aspirin

50

0.64 ± 0.045 (08.57%)

0.61 ± 0.054 (11.59%)

0.55 ± 0.049 (20.29%)

0.54 ± 0.053 (22.85%)

0.55 ± 0.049 (23.61%)

100

0.56 ± 0.036 (20.00%)

0.50 ± 0.049* (27.53%)

0.37 ± 0.058** (46.37%)

0.39 ± 0.062** (44.29%)

0.47 ± 0.062* (34.72%)

200

0.47 ± 0.040* (32.86%)

0.35 ± 0.067** (49.27%)

0.24 ± 0.045** (65.22%)

0.31 ± 0.053** (55.71%)

0.34 ± 0.062** (52.78%)

100

0.23 ± 0.040** (67.14%)

0.19 ± 0.017** (72.46%)

0.17 ± 0.031** (78.1%)

0.18 ± 0.022** (75.71%)

0.18 ± 0.036** (75.00%)

Experimental data are expressed as mean ± S.E.M. for group of at least six animals. One- way ANOVA was utilized as judgment test of significant differences
among groups followed by Dunnett’s multiple comparison post-test. A probability of *P < 0.05 or **P < 0.01 was considered significant from control. Protection (%)
is shown in parenthesis.
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Figure 2 Structures of isolated compounds (a) 2-hydroxybenzoic acid, (b) β-sitosterol.

Discussion
In view of its medicinal use in hyperactive airway disordered like bronchial spasms and asthma [3], P. verticillatum has been studied for its myorelaxant activity
using isolated guinea-pig tracheal tissue preparations.
While on the basis of its folk reputation as an antiinflammatory remedy [4], the plant has been tested for its
anti-inflammatory potential using carrageenan-induced
rat paw edema model.
When test for tracheorelaxant activity, P. verticillatum
caused relaxation of high K+ and CCh-induced contractions in isolated guinea-pig tracheal tissues with greater
potency against K+. The smooth muscle contraction of
different body systems including the airways depends
upon an increase in the cytoplasmic free Ca2+, which
activates the cellular contractile machinery. The increase in intracellular Ca2+ is due to either influx via
voltage-dependent Ca2+ channels (VDCs) or release from
intracellular stores in the sarcoplasmic reticulum. At concentrations higher than 30 mM, K+ is known to cause

smooth muscle contractions through the opening of
VDCs, consequently allowing inward movement of
extracellular Ca2+ originating a contractile effect; thus,
a substance causing inhibition of high K+ -induced contraction is considered as an inhibitor of Ca2+ influx [23].
Similar to the pattern of inhibitory effect of verapamil, a
standard Ca2+ antagonist [28], against K+ and CCh, a substance causing inhibition of high K+ at low concentrations
than its effect on CCh, may indicate the presence of
Ca2+ antagonist-like spasmolytic mechanism. To confirm
the Ca2+ antagonist-like effect of P. verticillatum, the
concentration-response curves (CRCs) of Ca2+ were constructed in the absence and presence of different doses of
the plant extract, where it displaced the CRCs of Ca2+ to
the right with suppression of the maximum response similar to the effect produced by verapamil, thus attesting the
presence Ca2+ antagonist-like constituents in the plant
extract. The Ca2+ antagonists are known to possess therapeutic potential in the management of hyperactive airways disorders [29,30]. Thus, the Ca2+ antagonist effect
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observed in this study may explain the medicinal use of
the plant in airways disorders, though additional mechanism cannot be ruled out.
The carrageenan-induced paw edema test is a wellestablished animal model of inflammation used to detect
the anti-inflammatory activity of test materials [25]. It
has been observed that the local edema is induced by
the sub-plantar injection of carrageenan that increases
progressively. Edema formation due to carrageenan injection in the rat paw is the biphasic event during 1–5 h;
the initial phase (1 to 1.5 h) is predominately a nonphagocytic edema followed by a second phase with increased edema formation that persists up to 5 h [31,32].
Different mediators are known to be involved in different stages of carrageenan-induced edema. The initial
phase (up to 1.5 h) is attributed to the release of histamine, 5-hydroxytryptamine, bradykinin, platelet activating factor and serotonin. Kinins (bradykinin and
kallikrein) are involved in both stages, and get released
from 1.5 to 2.5 h and at the last step inflammation is
continued until 5 h due to the release of lipid derived
eicosanoids (prostaglandins, leukotrienes, hydroperoxyeicosatetraenoic acid). A comprehensive phagocytic inflammation is observed at 3rd h followed by carrageenan
injection with large number of neutrophils and tissue
edema [25,31]. Our results showed significant (P < 0.01)
inhibition in carrageenan-induced paw edema model at
all test doses of anti-inflammatory activity of P. verticillatum with maximum effect at 3rd h. The observed
anti-inflammatory activity provides an evidence to the
folkloric use of P. verticillatum in inflammation.
Leukotrienes (LTs) are the downstream products of
arachidonic acid that exert pivotal biological functions
as well as pathogenic effects in a wide range of inflammatory processes. Polymorphonuclear leukocytes and
monocytes/macrophages are the major cells capable of
synthesizing LTs due to a high 5-Lipoxygenase activity
and represent crucial components in chronic inflammatory diseases [33-35]. The role of lipoxygenase is also
documented in carrageenan provoked edema [33]. Inhibition of lipoxygenase activity results in down regulation
of the pro-inflammatory activity of leukocytes and platelets [36], which may cause a diminished or delayed outcome of the inflammatory reaction. From a mechanistic
point of view, PR elicited marked inhibitory activity in
soybean lipoxygenase assay.
Phytochemically, the isolation of 2-hydroxybenzoic
acid and β-sitosterol strengthened our findings in a way
that the anti-inflammatory and antioxidant potential of
these compounds have been previously investigated
[37-39]; the effect of 2-hydroxybenzoic acid is known to
be mediated through lipoxygenase (LOX)/cyclooxygenase (COX) inhibition [40,41]. Keeping this in view, it can
also be speculated that the mechanism underlying the

anti-inflammatory activity of P. verticillatum is at least
in part due to LOX/COX inhibition, however the additional mechanism cannot be ruled out which may be
responsible for the effectiveness of this plant in hyperactive airways disorders.
Free radical generation plays a pivotal role in the
pathophysiology of inflammatory and airways disorders
[42,43]. P. verticillatum is known to possess strong antioxidant activity [8], which is likely to complement the
anti-inflammatory potential of this plant. Similarly, βsitosterol is known to possess the Ca2+ channel blocking
activity [22], which is again consistent with our findings,
showing Ca2+ antagonist activity of P. verticillatum.
There is paucity in traditional literature regarding
exact dose of the plant recommended to be used in airways disorders or as an external anti-inflammatory agent;
however, the observed effective doses were selected on the
basis of our experience of studying the possible mode of
actions of natural remedies for their effectiveness in airways disorders and inflammatory conditions [12,44-46].

Conclusions
These data indicate that P. verticillatum possesses tracheorelaxant, mediated possibly through the Ca2+ channel blockade and anti-inflammatory activities, which
may explain the medicinal use of this plant in airway
disorders and inflammatory complaints. However, detailed studies are warranted to ascertain the clinical significance of this natural product.
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